Company profile

convEyXO company profile

We are a Belgian biotech company driving therapeutic innovation, co-founded by Dr. Jean-Paul Prieels, former Senior VP of R&D at GSK Biologicals. Our mission is to develop advanced therapies for degenerative diseases, leveraging our proprietary platform based on immortalized MSC-derived small extracellular vesicles (sEVs or exosomes). These vesicles are engineered to enhance their natural anti-inflammatory and tissue repair properties through targeted miRNA. Our focus addresses critical health challenges, including osteoarthritis, Alzheimer’s disease, dermatological conditions, and metabolic dirsorders. By fostering strategic collaborations with academic leaders and pharmaceutical industry partners, we have built a strong scientific foundation and a clear pathway to..... For more information, log in to dureach.com to view the full company profile.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2019-04-30

Headquarters

Headquarters
Charleroi, Wallonia, Belgium
Postal code
6041
Country code
BE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
5
Total equity funding
$6.6M
Last funding
Grant / $1.8M / 2024-02-01
Last equity funding
Seed / $1.1M
Founders
3
Articles
3

Founders and investors

Founders

Frédéric TongletJean SmalJean-Paul Prieels

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.